Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.215 USD | -9.33% |
|
+10.00% | -58.98% |
16/07 | BioXcel Therapeutics Shares Rise After Preliminary Q2 Revenue Exceeds Estimates | MT |
01/07 | BioXcel Therapeutics, Inc.(NasdaqCM:BTAI) dropped from Russell Small Cap Completeness Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.98% | 5.03Cr | |
+19.34% | 13TCr | |
+22.71% | 12TCr | |
+23.26% | 2.79TCr | |
-19.20% | 2.1TCr | |
-15.13% | 1.69TCr | |
-14.64% | 1.62TCr | |
+9.52% | 1.48TCr | |
-46.10% | 1.48TCr | |
+50.37% | 1.41TCr |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Transcript : BioXcel Therapeutics, Inc. - Special Call